Cashu
Halper Sadeh probes Lisata Therapeutics' cash‑plus‑CVR sale over fiduciary and disclosure concerns
28 days ago
Stocks
Health Care
lsta
Lisata Therapeutics
NASDAQ: LSTA
-0.00 (-0.10%)
5.025
USD
At close at Mar 13, 20:39 UTC
Latest Lisata Therapeutics News
prnewswire.com
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
about 1 month ago
prnewswire.com
Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
about 1 month ago
prnewswire.com
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
about 2 months ago
prnewswire.com
Neurocrine Biosciences Presents Head-to-Head INGREZZA (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR
about 2 months ago
prnewswire.com
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
2 months ago
prnewswire.com
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference
2 months ago
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
2 months ago
prnewswire.com
Nona Biosciences Enters into Collaboration Agreement with Link Cell Therapies to Advance CAR-T Cell Therapies
2 months ago
prnewswire.com
Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
2 months ago
benzinga.com
6 Analysts Have This To Say About Harmony Biosciences Hldgs
2 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.